Related Experiment Video
Updated: Jan 25, 2026

A Full Skin Defect Model to Evaluate Vascularization of Biomaterials In Vivo
Published on: August 28, 2014
Attenuating Diabetic Vascular and Neuronal Defects by Targeting P2rx7
Sofia Pavlou1, Josy Augustine2, Rónán Cunning3
1Centre for Experimental Medicine, School of Medicine, Dentistry & Biomedical Science, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland, UK. s.pavlou@qub.ac.uk.
Abstract:
Retinal vascular and neuronal degeneration are established pathological features of diabetic retinopathy. Data suggest that defects in the neuroglial network precede the clinically recognisable vascular lesions in the retina. Therefore, new treatments that target early-onset neurodegeneration would be expected to have great value in preventing the early stages of diabetic retinopathy. Here, we show that the nucleoside reverse transcriptase inhibitor lamivudine (3TC), a newly discovered P2rx7 inhibitor, can attenuate progression of both neuronal and vascular pathology in diabetic retinopathy. We found that the expression of P2rx7 was increased in the murine retina as early as one month following diabetes induction. Compared to non-diabetic controls, diabetic mice treated with 3TC were protected against the formation of acellular capillaries in the retina. This occurred concomitantly with a maintenance in neuroglial function, as shown by improved a- and b-wave amplitude, as well as oscillatory potentials. An improvement in the number of GABAergic amacrine cells and the synaptophysin-positive area was also observed in the inner retina of 3TC-treated diabetic mice. Our data suggest that 3TC has therapeutic potential since it can target both neuronal and vascular defects caused by diabetes.
Insights
Lamivudine (3TC), a P2rx7 inhibitor, shows promise in treating diabetic retinopathy by protecting retinal neurons and blood vessels. This new treatment may prevent early-stage diabetic eye disease progression.
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Background:
- Diabetic retinopathy involves retinal vascular and neuronal damage.
- Neuroglial network defects may precede vascular lesions in diabetic retinopathy.
- Targeting early neurodegeneration could prevent diabetic retinopathy progression.
Purpose of the Study:
- To investigate the therapeutic potential of lamivudine (3TC) in a mouse model of diabetic retinopathy.
- To determine if 3TC, a P2rx7 inhibitor, can attenuate both neuronal and vascular pathology.
Main Methods:
- Assessed P2rx7 expression in diabetic mouse retinas.
- Evaluated the effect of 3TC treatment on retinal vascular and neuronal integrity.
- Measured electroretinogram (ERG) parameters (a- and b-wave, oscillatory potentials).
- Quantified GABAergic amacrine cells and synaptophysin-positive areas.
Main Results:
- P2rx7 expression was elevated in diabetic mouse retinas.
- 3TC treatment protected against acellular capillary formation in diabetic mice.
- 3TC preserved neuroglial function, indicated by improved ERG amplitudes.
- 3TC treatment increased the number of GABAergic amacrine cells and synaptophysin-positive area.
Conclusions:
- Lamivudine (3TC) demonstrates therapeutic potential for diabetic retinopathy.
- 3TC effectively targets both neuronal and vascular pathologies associated with diabetes.
- Inhibiting P2rx7 with 3TC may offer a novel treatment strategy for early diabetic retinopathy.
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Lumber Defects
Shakes are minor fractures that run along or across the wood's annual rings, while wane is...
Seedless Vascular Plants
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer

